This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in this journal  Social Bookmarking   What's this?

Nirmal Joshi, MD; Debra Q. Miller, MD

Arch Intern Med. 1997;157(13):1421-1428.

Abstract
Although several new antibiotics have recently become available, in several clinical instances conventional antibiotics may be equally efficacious at a considerably lower cost. In today's era of cost containment, it is particularly relevant to revisit older, inexpensive antibiotics to reexplore their role in the face of the emergence of resistant microorganisms and competition from newer agents. Doxycycline is one such antibiotic. It is an inexpensive, broad-spectrum antimicrobial agent that remains the drug of first choice for several infections. In addition, it can be used for a variety of other indications. Adverse effects are infrequent and relatively minor. While interactions occur with several medications, none of these interactions has significant adverse consequences.

Arch Intern Med. 1997;157:1421-1428

Author Affiliations
From the Division of General Internal Medicine, Department of Medicine, Pennsylvania State University, Hershey.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Rash Decisions
Arthur Krulewitz, Nirmal Joshi, and Debra Q. Miller
Arch Intern Med. 1998;158(2):191.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

In vitro cell compatibility and antibacterial activity of microencapsulated doxycycline designed for improved localized therapy of septic arthritis
Haerdi-Landerer et al.
J Antimicrob Chemother 2008;61:332-340.
ABSTRACT | FULL TEXT  

Effect of timing and duration of azithromycin therapy of leptospirosis in a hamster model
Moon et al.
J Antimicrob Chemother 2007;59:148-151.
ABSTRACT | FULL TEXT  

Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines
Agwuh and MacGowan
J Antimicrob Chemother 2006;58:256-265.
ABSTRACT | FULL TEXT  

Sustained-Release Formulation of Doxycycline Hyclate for Prophylaxis of Tick Bite Infection in a Murine Model of Lyme Borreliosis
Zeidner et al.
Antimicrob. Agents Chemother. 2004;48:2697-2699.
ABSTRACT | FULL TEXT  

Tetracyclines in Pediatrics Revisited
Shetty
CLIN PEDIATR 2002;41:203-209.
 

Community-Acquired Lower Respiratory Tract Infections : Etiology and Treatment
Guthrie
Chest 2001;120:2021-2034.
ABSTRACT | FULL TEXT  

Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance
Chopra and Roberts
Microbiol. Mol. Biol. Rev. 2001;65:232-260.
ABSTRACT | FULL TEXT  

An Unusual Presentation of Doxycycline-Induced Photosensitivity
Yong et al.
Pediatrics 2000;106:13e-13.
ABSTRACT | FULL TEXT  

Treatment for Community Acquired Pneumonia: More Support for Doxycycline
Ditmanson et al.
Arch Intern Med 1999;159:1814-1815.
FULL TEXT  

Revisiting Doxycycline
Dooley
Arch Intern Med 1998;158:1469-1470.
FULL TEXT  

Rash Decisions
Krulewitz et al.
Arch Intern Med 1998;158:191-191.
FULL TEXT  

In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies
Marzio et al.
Proc. Natl. Acad. Sci. USA 2001;98:6342-6347.
ABSTRACT | FULL TEXT